Joint Filer Information
Names: | Deerfield Mgmt, L.P., Deerfield Partners, L.P. and James E. Flynn |
Address: |
345 Park Avenue South, 12th Floor New York, NY 10010 |
Designated Filer: | Deerfield Management Company, L.P. |
Issuer and Ticker Symbol: | DA32 Life Science Tech Acquisition Corp. [DALS] |
Date of Event Requiring Statement: | July 28, 2023 |
The undersigned, Deerfield Mgmt, L.P., Deerfield Partners, L.P. and James E. Flynn, are jointly filing the attached Statement of Changes in Beneficial Ownership on Form 4 with Deerfield Management Company, L.P. with respect to the beneficial ownership of securities of DA32 Life Science Tech Acquisition Corp.
Signatures:
DEERFIELD PARTNERS, L.P.
By: Deerfield Mgmt, L.P., General Partner By: J.E. Flynn Capital, LLC, General Partner
By: /s/ Jonathan Isler Jonathan Isler, Attorney-In-Fact
|
DEERFIELD MGMT, L.P.
By: J.E. Flynn Capital, LLC, General Partner
By: /s/ Jonathan Isler Jonathan Isler, Attorney-In-Fact
|
JAMES E. FLYNN
By: /s/ Jonathan Isler Jonathan Isler, Attorney-In-Fact
|